Cibotercept is a fusion protein commercialized by Keros Therapeutics, with a leading Phase II program in Pulmonary Arterial Hypertension.

Pulmonary hypertension (PH) is a chronic, life-threatening condition involving high blood pressure in the arteries of the ...